Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | DAO | P14920 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HPGDS | O60760 | 1/20 | 0.41 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.41 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | RPS6KB2 | Q9UBS0 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL775357 | 0.90 | ALDH1A1 (0.44) | MEN1POLBRAB9AKMT2ADAO | |
| SCHEMBL7644385 | 0.89 | DAO (0.50) | MEN1POLBRAB9AKMT2ADAO | |
| SCHEMBL776619 | 0.89 | ALDH1A1 (0.47) | MEN1POLBRAB9AKMT2ADAO | |
| SCHEMBL775264 | 0.86 | MEN1 (0.49) | MEN1POLBRAB9AKMT2ADAO | |
| SCHEMBL10020293 | 0.84 | MEN1 (0.47) | MEN1POLBRAB9AKMT2ADAO | |
| SCHEMBL593023 | 0.79 | MEN1 (0.65) | MEN1POLBRAB9AKMT2ADAO | |
| SCHEMBL13891701 | 0.79 | HPGD (0.49) | MEN1POLBRAB9AKMT2ADAO | |
| SCHEMBL2615879 | 0.77 | MEN1 (0.63) | MEN1POLBRAB9AKMT2ADAO | |
| SCHEMBL2615881 | 0.77 | MEN1 (0.63) | MEN1POLBRAB9AKMT2ADAO | |
| Hydrochloric Acid SCHEMBL9447525 | 0.77 | MEN1 (0.63) | MEN1POLBRAB9AKMT2ADAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8663451-B2 | Linker, impedance biochip, and method of quantitatively detecting target analyte in fluid sample using the biochip | NATIONAL TAIWAN UNIVERSITY (TW) | 2014-03-04 | — | — | US | claimed |
| US-20120067742-A1 | LINKER, IMPEDANCE BIOCHIP, AND METHOD OF QUANTITATIVELY DETECTING TARGET ANALYTE IN FLUID SAMPLE USING THE BIOCHIP | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-03-22 | — | — | US | claimed |
| US-8663451-B2 | Linker, impedance biochip, and method of quantitatively detecting target analyte in fluid sample using the biochip | NATIONAL TAIWAN UNIVERSITY (TW) | 2014-03-04 | — | — | US | disclosed |
| US-20120067742-A1 | LINKER, IMPEDANCE BIOCHIP, AND METHOD OF QUANTITATIVELY DETECTING TARGET ANALYTE IN FLUID SAMPLE USING THE BIOCHIP | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120067742-A1 | LINKER, IMPEDANCE BIOCHIP, AND METHOD OF QUANTITATIVELY DETECTING TARGET ANALYTE IN FLUID SAMPLE USING THE BIOCHIP | EPCAM, CA13, CD44 | MEN1 2222/4885POLB 4450/4885RAB9A 4661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.